J. F. Okulicz and O. Lambotte, Epidemiology and clinical characteristics of elite controllers, Curr Opin HIV AIDS, vol.6, issue.3, pp.163-168, 2011.

O. Lambotte, F. Boufassa, and Y. Madec, HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.41, issue.7, pp.1053-1056, 2005.

B. D. Walker, Elite control of HIV Infection: implications for vaccines and treatment, Top HIV Med Publ Int AIDS Soc USA, vol.15, issue.4, pp.134-136, 2007.

A. D. Olson, L. Meyer, and M. Prins, An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration, PloS One, vol.9, issue.1, p.86719, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01368387

A. Lamine, A. Caumont-sarcos, and M. Chaix, Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study), AIDS Lond Engl, vol.21, issue.8, pp.1043-1045, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00166186

J. N. Blankson, J. R. Bailey, and S. Thayil, Isolation and characterization of replicationcompetent human immunodeficiency virus type 1 from a subset of elite suppressors, J Virol, vol.81, issue.5, pp.2508-2518, 2007.

A. Sáez-cirión, G. Pancino, M. Sinet, A. Venet, and O. Lambotte, ANRS EP36 HIV CONTROLLERS study group. HIV controllers: how do they tame the virus?, Trends Immunol, vol.28, issue.12, pp.532-540, 2007.

T. Miura, M. A. Brockman, and A. Schneidewind, HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition, J Virol, vol.83, issue.6, pp.2743-2755, 2009.

A. Sáez-cirión, C. Lacabaratz, and O. Lambotte, HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proc Natl Acad Sci, vol.104, issue.16, pp.6776-6781, 2007.

S. J. Potter, C. Lacabaratz, and O. Lambotte, Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study, J Virol, vol.81, issue.24, pp.13904-13915, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00193768

S. Hua, C. Lécuroux, and A. Sáez-cirión, Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers, PloS One, vol.9, issue.7, p.101920, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01420529

A. Sáez-cirión, M. Sinet, and S. Y. Shin, Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses, J Immunol, 2009.

N. Noel, R. Peña, and A. David, Long-term Spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation, J Virol, 2016.

N. Noel, N. Lerolle, and C. Lécuroux, Immunologic and virologic progression in HIV controllers: the role of viral "blips" and immune activation in the ANRS CO21 CODEX study
URL : https://hal.archives-ouvertes.fr/pasteur-01415218

V. Avettand-fènoël, L. Hocqueloux, and J. Ghosn, Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications, Clin Microbiol Rev, vol.29, issue.4, pp.859-880, 2016.

O. Lambotte, J. Pollara, and F. Boufassa, High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers, PloS One, vol.8, issue.9, p.74855, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01420536

J. F. Okulicz, V. C. Marconi, and M. L. Landrum, Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study, J Infect Dis, vol.200, issue.11, pp.1714-1723, 2009.

P. W. Hunt, J. Brenchley, and E. Sinclair, Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy, J Infect Dis, vol.197, issue.1, pp.126-133, 2008.

F. Boufassa, A. Saez-cirion, and J. Lechenadec, CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PloS One, vol.6, issue.4, p.18726, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01420582

N. Noel, F. Boufassa, and C. Lécuroux, Elevated IP10 levels are associated with immune activation and low CD4 + T-cell counts in HIV controller patients, AIDS Lond Engl, vol.28, issue.4, pp.467-476, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01420524

F. H. Côrtes, C. Passaes, and G. Bello, HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles, J Acquir Immune Defic Syndr, vol.68, issue.4, pp.377-385, 1999.

K. C. Groves, D. F. Bibby, and D. A. Clark, Disease Progression in HIV-1-Infected Viremic Controllers, J Acquir Immune Defic Syndr, vol.61, issue.4, pp.407-416, 1999.

V. Avettand-fènoël, M. Chaix, and S. Blanche, LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01), J Med Virol, vol.81, issue.2, pp.217-223, 2009.

J. Pollara, L. Hart, and F. Brewer, High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses, Cytom Part J Int Soc Anal Cytol, vol.79, issue.8, pp.603-612, 2011.

A. Sáez-cirión, S. Y. Shin, P. Versmisse, F. Barré-sinoussi, and G. Pancino, Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses, Nat Protoc, vol.5, issue.6, pp.1033-1041, 2010.

Y. Madec, F. Boufassa, and K. Porter, Natural history of HIV-control since seroconversion, AIDS Lond Engl, vol.27, issue.15, pp.2451-2460, 2013.

H. Hatano, E. L. Delwart, and P. J. Norris, Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy, J Virol, vol.83, issue.1, pp.329-335, 2009.

J. P. Williams, J. Hurst, and W. Stöhr, HIV-1 DNA predicts disease progression and posttreatment virological control, eLife, vol.3, p.3821, 2014.

S. A. Yukl, E. Sinclair, and M. Somsouk, A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells, AIDS Lond Engl, vol.28, issue.3, pp.439-442, 2014.

H. Hatano, M. Somsouk, and E. Sinclair, Comparison of HIV DNA and RNA in gutassociated lymphoid tissue of HIV-infected controllers and noncontrollers, AIDS Lond Engl, vol.27, issue.14, pp.2255-2260, 2013.

A. Damouche, T. Lazure, and V. Avettand-fènoël, Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection, PLoS Pathog, vol.11, issue.9, p.1005153, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01207287

A. Sáez-cirión, C. Hamimi, and A. Bergamaschi, Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood, vol.118, issue.4, pp.955-964, 2011.

C. Lécuroux, A. Sáez-cirión, and I. Girault, Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers, J Virol, vol.88, issue.1, pp.176-187, 2014.

P. D. Burbelo, A. Bayat, and C. S. Rhodes, HIV antibody characterization as a method to quantify reservoir size during curative interventions, J Infect Dis, vol.209, issue.10, pp.1613-1617, 2014.

L. D. Rasmussen, M. T. May, and G. Kronborg, Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide populationbased cohort study, Lancet HIV, vol.2, issue.7, pp.288-298, 2015.

T. A. Crowell, K. A. Gebo, and J. N. Blankson, Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection, J Infect Dis, vol.211, issue.11, pp.1692-1702, 2015.

B. Dominguez-molina, L. A. Rodriguez, and C. , Analysis of Non-AIDS-Defining Events in HIV Controllers, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.62, issue.10, pp.1304-1309, 2016.